+91-22-48913909
Fincash »మ్యూచువల్ ఫండ్స్ »2018 కోసం ఉత్తమ పనితీరు రంగ నిధులు
Table of Contents
- పనితీరు ఆధారంగా 2019 కోసం టాప్ 10 పెర్ఫార్మింగ్ సెక్టార్ మ్యూచువల్ ఫండ్స్
- 2019 కోసం ఉత్తమ పనితీరు రంగ నిధులు
Top 10 Equity - Sectoral Funds
2019 కోసం ఉత్తమ 10 పనితీరు రంగ నిధులు
సెక్టార్మ్యూచువల్ ఫండ్స్ ఒక నిర్దిష్ట రంగానికి చెందిన కంపెనీల ఈక్విటీ షేర్లలో వారి ఫండ్ డబ్బులో ప్రధాన వాటాను పెట్టుబడి పెట్టే పథకాన్ని చూడండి. ఈ పథకాలను వెతుకుతున్న వ్యక్తులు కోరుకుంటారుహై రిటర్న్స్ వారి పెట్టుబడిపై aఅధిక ప్రమాదం ఆకలి. మ్యూచువల్ ఫండ్స్ సాధారణంగా వారి పథకాలను అందించే కొన్ని రంగాలలో మౌలిక సదుపాయాలు, ce షధ, బ్యాంకింగ్ మరియు ఆర్థిక సేవలు మరియు సహజ వనరులు మరియు కొత్త శక్తి ఉన్నాయి. 2019 సంవత్సరానికి రంగాల నిధుల పనితీరు చాలా బాగుంది. ఆర్థిక వ్యవస్థలో జరిగిన పరిణామాలతో, అనేక రంగాల నిధులు తమ పెట్టుబడులపై సానుకూల రాబడిని సాధించాయి. కాబట్టి, వారి పనితీరు (రాబడి) ఆధారంగా 2019 సంవత్సరానికి టాప్ మరియు బెస్ట్ 10 పెర్ఫార్మింగ్ సెక్టార్ మ్యూచువల్ ఫండ్లలో కొన్నింటిని చూద్దాం.
Talk to our investment specialist
పనితీరు ఆధారంగా 2019 కోసం టాప్ 10 పెర్ఫార్మింగ్ సెక్టార్ మ్యూచువల్ ఫండ్స్
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹44.1457
↑ 0.06 ₹874 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹270.142
↓ -2.19 ₹1,042 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹422.458
↑ 5.77 ₹3,611 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.2953
↓ -0.28 ₹1,184 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹47.368
↓ -0.04 ₹1,563 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹236.829
↓ -0.05 ₹6,047 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹40.1454
↑ 0.14 ₹967 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹148.68
↑ 0.36 ₹815 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹496.598
↓ -3.09 ₹8,081 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹59.07
↑ 0.17 ₹1,410 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 29 Apr 25
2019 కోసం ఉత్తమ పనితీరు రంగ నిధులు
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (29 Apr 25) ₹44.1457 ↑ 0.06 (0.13 %) Net Assets (Cr) ₹874 on 31 Mar 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.41 Information Ratio 0.35 Alpha Ratio 15.98 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,888 31 Mar 22 ₹22,193 31 Mar 23 ₹22,783 31 Mar 24 ₹36,820 31 Mar 25 ₹42,656 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 1.1% 3 Month -1.1% 6 Month -10.1% 1 Year 6.2% 3 Year 25.2% 5 Year 31.8% 10 Year 15 Year Since launch 9% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.53 Yr. Mahesh Bendre 1 Jul 24 0.75 Yr. Data below for LIC MF Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 54.85% Basic Materials 10.74% Consumer Cyclical 8.43% Utility 8.18% Financial Services 6.2% Real Estate 2.35% Technology 2.22% Communication Services 2.04% Energy 0.78% Health Care 0.63% Asset Allocation
Asset Class Value Cash 3.57% Equity 96.43% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹40 Cr 408,127
↓ -48,113 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹37 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹27 Cr 724,927 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹25 Cr 571,332 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹24 Cr 490,363 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹22 Cr 332,049 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001032% ₹21 Cr 983,002 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 5004802% ₹20 Cr 66,848 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹20 Cr 126,914
↑ 5,575 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹20 Cr 476,469
↓ -13 2. UTI Healthcare Fund
CAGR/Annualized return of 14.8% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (29 Apr 25) ₹270.142 ↓ -2.19 (-0.80 %) Net Assets (Cr) ₹1,042 on 31 Mar 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.66 Information Ratio -0.23 Alpha Ratio 1.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,396 31 Mar 22 ₹19,596 31 Mar 23 ₹17,899 31 Mar 24 ₹27,884 31 Mar 25 ₹33,479 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 0.7% 3 Month 1.4% 6 Month -3.2% 1 Year 20.2% 3 Year 20.2% 5 Year 21.9% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.92 Yr. Data below for UTI Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 98.03% Basic Materials 1.18% Asset Allocation
Asset Class Value Cash 0.79% Equity 99.21% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹121 Cr 700,000
↓ -25,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹61 Cr 420,000
↓ -44,949 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323314% ₹46 Cr 174,885
↓ -13,514 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY4% ₹45 Cr 396,000
↓ -36,608 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹42 Cr 275,250
↓ -34,061 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹38 Cr 74,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹37 Cr 56,271 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹32 Cr 465,000
↓ -92,701 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹32 Cr 56,000
↓ -5,480 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹31 Cr 63,840 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.6% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (28 Apr 25) ₹422.458 ↑ 5.77 (1.38 %) Net Assets (Cr) ₹3,611 on 31 Mar 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.77 Information Ratio 0.67 Alpha Ratio 2.51 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,177 31 Mar 22 ₹19,486 31 Mar 23 ₹19,107 31 Mar 24 ₹30,178 31 Mar 25 ₹36,162 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 2.6% 3 Month 6.4% 6 Month 1.7% 1 Year 22.2% 3 Year 24.1% 5 Year 24.8% 10 Year 15 Year Since launch 15.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.84 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 90.36% Basic Materials 6.6% Asset Allocation
Asset Class Value Cash 3.04% Equity 96.96% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹486 Cr 2,800,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH7% ₹241 Cr 2,200,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹217 Cr 375,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹173 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹170 Cr 840,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹158 Cr 300,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹136 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹134 Cr 2,100,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹128 Cr 800,000 Ami Organics Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹122 Cr 500,000 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.2% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (29 Apr 25) ₹29.2953 ↓ -0.28 (-0.93 %) Net Assets (Cr) ₹1,184 on 31 Mar 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.42 Information Ratio 0.57 Alpha Ratio 2.09 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,489 31 Mar 22 ₹19,237 31 Mar 23 ₹17,775 31 Mar 24 ₹28,060 31 Mar 25 ₹32,066 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 2.3% 3 Month 1.5% 6 Month -3.6% 1 Year 15.8% 3 Year 20.3% 5 Year 21.8% 10 Year 15 Year Since launch 12.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.07 Yr. Rajat Srivastava 16 Sep 24 0.54 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 93.43% Basic Materials 2.34% Asset Allocation
Asset Class Value Cash 4.24% Equity 95.76% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹140 Cr 804,300 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA7% ₹86 Cr 741,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹71 Cr 490,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹67 Cr 101,255
↑ 28,620 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹61 Cr 303,240
↓ -57,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹61 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹60 Cr 855,100 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹46 Cr 956,991
↑ 50,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY3% ₹41 Cr 361,555
↓ -353,000 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA3% ₹39 Cr 274,871 5. IDFC Infrastructure Fund
CAGR/Annualized return of 11.6% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (29 Apr 25) ₹47.368 ↓ -0.04 (-0.09 %) Net Assets (Cr) ₹1,563 on 31 Mar 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio 0.11 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹20,153 31 Mar 22 ₹24,848 31 Mar 23 ₹27,324 31 Mar 24 ₹47,064 31 Mar 25 ₹50,038 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 3.1% 3 Month 3.5% 6 Month -7.3% 1 Year 1.2% 3 Year 26.1% 5 Year 35.7% 10 Year 15 Year Since launch 11.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.19 Yr. Ritika Behera 7 Oct 23 1.48 Yr. Gaurav Satra 7 Jun 24 0.82 Yr. Data below for IDFC Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 56.16% Utility 13.16% Basic Materials 9.87% Communication Services 4.63% Energy 3.69% Financial Services 2.72% Consumer Cyclical 2.55% Technology 2.5% Health Care 1.93% Asset Allocation
Asset Class Value Cash 2.79% Equity 97.21% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹76 Cr 443,385 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT4% ₹64 Cr 183,173 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325384% ₹58 Cr 50,452 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE4% ₹58 Cr 452,706 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹57 Cr 4,797,143 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 19 | BHARTIARTL4% ₹57 Cr 330,018 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹43 Cr 365,137 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Oct 19 | BEL3% ₹43 Cr 1,431,700 KEC International Ltd (Industrials)
Equity, Since 30 Jun 24 | 5327143% ₹40 Cr 512,915 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS2% ₹39 Cr 12,400,122 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.4% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (29 Apr 25) ₹236.829 ↓ -0.05 (-0.02 %) Net Assets (Cr) ₹6,047 on 31 Mar 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio 0.46 Information Ratio 1.68 Alpha Ratio 8.45 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹18,903 31 Mar 22 ₹21,132 31 Mar 23 ₹23,026 31 Mar 24 ₹37,539 31 Mar 25 ₹43,201 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 4.3% 3 Month 1.1% 6 Month -3.4% 1 Year 9.1% 3 Year 29.7% 5 Year 32.1% 10 Year 15 Year Since launch 13.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 3.15 Yr. R. Janakiraman 1 Apr 13 12.01 Yr. Sandeep Manam 18 Oct 21 3.45 Yr. Data below for Franklin India Opportunities Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Consumer Cyclical 17.84% Financial Services 14.15% Health Care 11.48% Communication Services 8.89% Basic Materials 8.36% Technology 7.72% Industrials 6.32% Consumer Defensive 4.6% Energy 4.19% Real Estate 2.15% Utility 1.44% Asset Allocation
Asset Class Value Cash 10.49% Equity 89.51% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK6% ₹374 Cr 2,043,971
↑ 308,675 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹253 Cr 1,987,098 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL4% ₹233 Cr 1,342,233 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 30 Jun 24 | HINDUNILVR3% ₹182 Cr 803,952
↑ 242,198 Mphasis Ltd (Technology)
Equity, Since 30 Nov 24 | 5262993% ₹178 Cr 710,533 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹170 Cr 637,966 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹165 Cr 12,833,401 Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jul 24 | NAUKRI3% ₹155 Cr 216,138 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Jan 10 | ICICIBANK3% ₹155 Cr 1,148,695 APL Apollo Tubes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | APLAPOLLO3% ₹152 Cr 998,385 7. L&T Business Cycles Fund
CAGR/Annualized return of 13.9% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (29 Apr 25) ₹40.1454 ↑ 0.14 (0.36 %) Net Assets (Cr) ₹967 on 31 Mar 25 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio 0.36 Information Ratio 0.76 Alpha Ratio 7.61 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,684 31 Mar 22 ₹21,100 31 Mar 23 ₹22,192 31 Mar 24 ₹31,871 31 Mar 25 ₹36,168 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 3.2% 3 Month 4.6% 6 Month -6.7% 1 Year 8% 3 Year 21.2% 5 Year 27.6% 10 Year 15 Year Since launch 13.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Venugopal Manghat 20 Aug 14 10.62 Yr. Gautam Bhupal 1 Jun 23 1.83 Yr. Sonal Gupta 1 Jun 23 1.83 Yr. Data below for L&T Business Cycles Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Financial Services 32.49% Industrials 28.36% Consumer Cyclical 15.18% Basic Materials 11.48% Energy 6.32% Technology 1.3% Real Estate 0.86% Asset Allocation
Asset Class Value Cash 2.75% Equity 97.25% Top Securities Holdings / Portfolio
Name Holding Value Quantity ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK6% ₹57 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE5% ₹51 Cr 401,700 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | 5002515% ₹51 Cr 95,680 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX5% ₹50 Cr 94,300 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK5% ₹45 Cr 246,800 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 22 | BEL3% ₹30 Cr 1,000,000 Larsen & Toubro Ltd (Industrials)
Equity, Since 31 Aug 14 | LT3% ₹29 Cr 81,830 Blue Star Ltd (Industrials)
Equity, Since 31 Aug 14 | BLUESTARCO3% ₹26 Cr 119,800 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5328103% ₹25 Cr 603,200 Power Mech Projects Ltd (Industrials)
Equity, Since 31 Oct 22 | POWERMECH3% ₹25 Cr 90,800 8. Canara Robeco Infrastructure
CAGR/Annualized return of 14.9% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (29 Apr 25) ₹148.68 ↑ 0.36 (0.24 %) Net Assets (Cr) ₹815 on 31 Mar 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio 0.36 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,577 31 Mar 22 ₹22,500 31 Mar 23 ₹25,245 31 Mar 24 ₹38,923 31 Mar 25 ₹44,217 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 2.9% 3 Month 4.9% 6 Month -5.9% 1 Year 8.8% 3 Year 25.8% 5 Year 32.8% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 3.77 Yr. Shridatta Bhandwaldar 29 Sep 18 6.51 Yr. Data below for Canara Robeco Infrastructure as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 46.4% Utility 13.59% Basic Materials 10.17% Energy 8.37% Financial Services 6.86% Communication Services 2.91% Consumer Cyclical 2.9% Technology 2.74% Real Estate 1.5% Asset Allocation
Asset Class Value Cash 4.56% Equity 95.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT6% ₹52 Cr 149,401 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325555% ₹38 Cr 1,066,480
↓ -65,186 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE4% ₹32 Cr 254,250
↑ 4,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO4% ₹30 Cr 58,250
↓ -9,000 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004004% ₹29 Cr 785,000 State Bank of India (Financial Services)
Equity, Since 31 Jul 24 | SBIN4% ₹29 Cr 370,000 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328983% ₹28 Cr 957,546 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Jul 19 | BEL3% ₹28 Cr 919,000 Power Finance Corp Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5328103% ₹27 Cr 660,000 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 24 | BHARTIARTL3% ₹24 Cr 136,600 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.5% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (29 Apr 25) ₹496.598 ↓ -3.09 (-0.62 %) Net Assets (Cr) ₹8,081 on 31 Mar 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 0.35 Information Ratio -0.49 Alpha Ratio -4.46 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,447 31 Mar 22 ₹20,234 31 Mar 23 ₹18,871 31 Mar 24 ₹29,909 31 Mar 25 ₹33,564 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 3.2% 3 Month 4.7% 6 Month -2.1% 1 Year 15.4% 3 Year 20% 5 Year 22.5% 10 Year 15 Year Since launch 20.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 20.01 Yr. Kinjal Desai 25 May 18 6.86 Yr. Data below for Nippon India Pharma Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 99.46% Asset Allocation
Asset Class Value Cash 0.54% Equity 99.46% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA13% ₹1,085 Cr 6,256,349
↓ -300,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹750 Cr 1,298,808 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002577% ₹588 Cr 2,898,126
↓ -200,000 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹462 Cr 3,200,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹429 Cr 648,795 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY5% ₹419 Cr 3,662,170 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO4% ₹291 Cr 1,011,921 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433504% ₹285 Cr 2,831,564
↓ -11,667 Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | ABBOTINDIA3% ₹279 Cr 90,933
↓ -5,052 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434273% ₹276 Cr 3,627,277 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 10.7% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (29 Apr 25) ₹59.07 ↑ 0.17 (0.29 %) Net Assets (Cr) ₹1,410 on 31 Mar 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio 0.05 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,093 31 Mar 22 ₹22,504 31 Mar 23 ₹23,767 31 Mar 24 ₹40,140 31 Mar 25 ₹41,997 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 29 Apr 25 Duration Returns 1 Month 3.3% 3 Month 1.5% 6 Month -6.9% 1 Year 2.2% 3 Year 24.4% 5 Year 31.2% 10 Year 15 Year Since launch 10.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.58 Yr. Sagar Gandhi 1 Mar 25 0.08 Yr. Data below for Invesco India Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 54.81% Consumer Cyclical 8.5% Basic Materials 8.35% Utility 6.83% Communication Services 6.41% Health Care 4.5% Technology 2.94% Energy 2.55% Financial Services 2.01% Real Estate 1.45% Asset Allocation
Asset Class Value Cash 1.66% Equity 98.34% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Aug 21 | BHARTIARTL6% ₹90 Cr 521,351 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹57 Cr 1,975,592
↓ -121,838 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390064% ₹57 Cr 37,885
↓ -755 ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical)
Equity, Since 30 Jun 23 | ZFCVINDIA4% ₹52 Cr 40,213
↑ 3,977 Supreme Industries Ltd (Industrials)
Equity, Since 30 Apr 24 | 5099304% ₹49 Cr 144,264
↑ 24,429 Jyoti CNC Automation Ltd (Industrials)
Equity, Since 31 Jan 24 | JYOTICNC3% ₹48 Cr 452,265 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Jun 24 | APOLLOHOSP3% ₹47 Cr 71,172
↑ 18,503 KEC International Ltd (Industrials)
Equity, Since 31 Jan 25 | 5327143% ₹44 Cr 567,255
↑ 72,158 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT3% ₹43 Cr 123,555
↓ -25,817 Transformers & Rectifiers (India) Ltd (Industrials)
Equity, Since 30 Jun 24 | TARIL3% ₹43 Cr 795,318
↓ -105,820
ఇక్కడ అందించిన సమాచారం ఖచ్చితమైనదని నిర్ధారించడానికి అన్ని ప్రయత్నాలు జరిగాయి. ఏదేమైనా, డేటా యొక్క ఖచ్చితత్వానికి సంబంధించి ఎటువంటి హామీలు ఇవ్వబడవు. ఏదైనా పెట్టుబడి పెట్టడానికి ముందు దయచేసి స్కీమ్ సమాచార పత్రంతో ధృవీకరించండి.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved